These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26567722)

  • 41. Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment.
    Morse SA; Dang A; Thakur V; Zhang R; Reisin E
    Am J Med Sci; 2003 Apr; 325(4):194-201. PubMed ID: 12695724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium channel blockers suppress daily variations of blood pressure in hypertensive patients with end-stage renal diseases.
    Takenaka T; Sueyoshi K; Arai J; Watanabe Y; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2014; 36(2):78-82. PubMed ID: 24625333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The controversies of diagnosing and treating hypertension among hemodialysis patients.
    Agarwal R
    Semin Dial; 2012 Jul; 25(4):370-6. PubMed ID: 22686564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What should be the goal blood pressure in nondiabetic chronic kidney disease?
    Schneider MP; Hilgers KF
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The internist's role in treating hypertension in hemodialysis patients.
    Hirsch S
    QJM; 2009 Jul; 102(7):501-7. PubMed ID: 19383610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapy of Hypertension in Chronic Dialysis Patients.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2062-2075. PubMed ID: 27797886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension in dialysis: pathophysiology and treatment.
    D'Amico M; Locatelli F
    J Nephrol; 2002; 15(4):438-45. PubMed ID: 12243377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. We Hold Antihypertensives Prior To Dialysis.
    Krishnan N; Peixoto AJ
    Semin Dial; 2016 Jul; 29(4):323-5. PubMed ID: 27113685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiazide diuretics in advanced chronic kidney disease.
    Agarwal R; Sinha AD
    J Am Soc Hypertens; 2012; 6(5):299-308. PubMed ID: 22951101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.
    Thompson S; Hemmelgarn B; Wiebe N; Majumdar S; Klarenbach S; Jindal K; Manns B; Mortis G; Campbell P; Tonelli M;
    J Nephrol; 2012; 25(6):944-53. PubMed ID: 23147684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease.
    Helal I; Al-Rowaie F; Abderrahim E; Kheder A
    Saudi J Kidney Dis Transpl; 2017; 28(2):253-260. PubMed ID: 28352004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of hypertension in CKD: beyond the guidelines.
    Judd E; Calhoun DA
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):116-22. PubMed ID: 25704348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and availability of doxazosin in treating hypertensive patients with chronic renal failure.
    Mori Y; Matsubara H; Nose A; Shibasaki Y; Masaki H; Kosaki A; Okigaki M; Fujiyama S; Tanaka-Uchiyama Y; Hasegawa T; Iba O; Tateishi E; Amano K; Iwasaka T
    Hypertens Res; 2001 Jul; 24(4):359-63. PubMed ID: 11510747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Hypertension in Chronic Kidney Disease: Consensus Statement by an Expert Panel of Indian Nephrologists.
    Abraham G; Arun KN; Gopalakrishnan N; Renuka S; Pahari DK; Deshpande P; Isaacs R; Chafekar DS; Kher V; Almeida AF; Sakhuja V; Sundar S; Gulati S; Abraham A; Padmanaban R
    J Assoc Physicians India; 2017 Feb; 65(2 Suppl):6-22. PubMed ID: 28829108
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic effect of bromocriptine together with the established treatment for hypertension in patients undergoing peritoneal dialysis.
    Mejía-Rodríguez O; Alvarez-Aguilar C; Ledesma-Ramírez M; Paniagua-Sierra R
    Proc West Pharmacol Soc; 2004; 47():122-4. PubMed ID: 15633631
    [No Abstract]   [Full Text] [Related]  

  • 57. Depression and Medication Adherence in Patients on Hemodialysis.
    Kauric-Klein Z
    Curr Hypertens Rev; 2017; 13(2):138-143. PubMed ID: 29205118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive Medications in End-Stage Renal Disease.
    Denker MG; Cohen DL
    Semin Dial; 2015; 28(4):330-6. PubMed ID: 25877881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease.
    Schmitt KE; Edie CF; Laflam P; Simbartl LA; Thakar CV
    Am J Nephrol; 2010; 32(6):541-8. PubMed ID: 21042012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical Activity In Renal Disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial.
    Thompson S; Wiebe N; Gyenes G; Davies R; Radhakrishnan J; Graham M
    Trials; 2019 Feb; 20(1):109. PubMed ID: 30736832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.